B Cell based Mass Spectrometry Assay Service
Creative Biolabs' B Cell-based mass spectrometry assay offers a powerful solution to streamline your antibody discovery pipeline. We provide a comprehensive service that delivers precise, actionable data, guiding your research and development efforts with unparalleled efficiency. By offering complete molecular characterization of potential antibody candidates, we ensure you can confidently advance with the most promising leads, accelerating your project's success.
Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Background of Mass Spectrometry Assay
Mass spectrometry is a cutting-edge tool for protein component analysis. This technique can determine the mass of various molecules, measuring the mass-to-charge ratio of their ions, the relative molecular mass of a compound, and the relative abundance and mass of isotopes of an element that can be interpreted to amino acid sequences and post-translational modification information of the epitope peptide. With tremendous improvement in the ionization approach, various mass spectrometry-based assays are used for determining antigen epitopes interacting with antibodies.
To explore how our services can be tailored to meet the specific requirements of your project, request a consultation.
Fig.1 Comparison of the immunoaffinity mass spectrometry assay (IAMS) and ELISA platforms. 1
What We Can Offer
Mass Spectrometry-based Cancer Epitope Analysis Service at Creative Biolabs
The mass spectrometry technique can determine both the amino acid sequences and the structure of the epitope that binds to an antibody in solution. Creative Biolabs provides integrated cancer epitope analysis services, including sample preparation, mass spectrometry, and data analysis.
Highlights
Precision Single-Cell Isolation
We use advanced microfluidics to isolate individual B cells from diverse samples, ensuring each antibody clone is captured and analyzed independently. This preserves the native immune repertoire's integrity.
Unparalleled Mass Spectrometry
Our platform combines high-resolution mass spectrometry with proprietary workflows for in-depth analysis of secreted antibodies. This provides an accurate molecular fingerprint, including post-translational modifications and precise mass.
Comprehensive Epitope Mapping
We analyze the antibody's interaction with the antigen at a molecular level, precisely mapping the binding epitope. This crucial step determines whether the epitope is linear or conformational, guiding your therapeutic design.
In-Depth Molecular Insight
Our process offers a deeper look into the B cell's biology, providing a comprehensive characterization that goes beyond simple sequencing. This holistic approach accelerates lead selection and reduces costly late-stage failures.
To initiate a collaborative discussion regarding your project's specific requirements and obtain a comprehensive proposal - Get a quote today.
Customer Reviews
-
Streamlined Workflow
We were able to bypass several time-consuming steps in our traditional discovery process. The clear, actionable data from the mass spectrometry assay allowed us to move from lead identification to functional validation much faster than we ever anticipated. - Tos a.
-
Data-Driven Decisions
The detailed molecular fingerprints provided by Creative Biolabs gave us the confidence to select the best lead candidates early on. We could see subtle post-translational modifications and glycosylation patterns that are crucial for therapeutic development, avoiding costly late-stage failures. - Krs i.
FAQs
How does your assay differ from traditional phage display or hybridoma technology?
Our assay directly analyzes antibodies secreted from single, native B cells, avoiding the biases and limitations of library-based approaches. This allows us to capture the full diversity of the immune repertoire, including rare clones that might be missed by conventional methods, ensuring you find the best possible candidate.
What kind of data will I receive from the assay?
You will receive a comprehensive report with a precise molecular fingerprint of each antibody, including its exact mass, amino acid sequence information, and details on post-translational modifications. We also provide data on epitope mapping and can present this information as a 3D structural model of the binding site.
Related Services
High-Throughput Antibody Production Platform
Our platform provides comprehensive and rapid antibody development services, from gene synthesis to antibody delivery. We can produce various formats, including full-length antibodies, Fab fragments, scFvs, and VHHs, with high purity for your research needs.
Learn More →
Antibody Engineering
Our platform offers extensive protein engineering services, including antibody humanization, affinity maturation, and other optimizations to enhance the therapeutic properties of your lead candidates.
Learn More →
How to Contact Us
Creative Biolabs' professional team can offer clients comprehensive cancer epitope analysis services. Additionally, we can help you plan the research program that best fits your purpose and advances your research. Please contact us and let us know what we can do for you.
Reference
-
Bringans, Scott et al. "The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease." Proteomes vol. 8,4 31. 28 Oct. 2020. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/proteomes8040031
For Research Use Only | Not For Clinical Use
